Leukemias/Lymphomas Flashcards
Where do lymphomas originate?
Secondary lymphatic structures-begin in cells of the immune system (lymph nodes, spleen)
Types of lymphoblastic neoplasms
acute lymphoblastic leukemias/lymphomas and chronic lymphoblastic leukemias/lymphomas
How are acute lymphoblastic leukemias/lymphomas classified?
Precursor is either B-cell or T-cell lymphoblastic leukemia or lymphoma
Most common form of childhood leukemia
B-ALL. Acute lymphoblastic leukemia arising from precursor B-cell lymphoblastic leukemia
How to diagnose B-cell ALL (leukemia)?
Bone marrow smear- fine chromatin pattern, high N/C ratio, 1-2 prominent nucleoli
Prognosis of child precursor B-cell ALL (leukemia?)
Complete remission in more than 90%, but translocations involving the MLL gene at 11q23 have poor prognosis
Significance of MLL gene
Translocations in this gene at 11q23 in B-cell ALL (leukemia) have poor prognosis
2 basic categories of lymphomas
Hodgkin and Non-Hodgkin lymphoma
Characteristics of all leukemias
Anemia (fatigue), thrombocytopenia (bleeding), and low white cell count (infections)
85% of acute lymphoblastic leukemias are…
B-cell leukemias
What age would you suspect of a patient diagnosed with acute lymphoblastic leukemia/lymphoma?
3-7 years
4 year old child presents with easy brusing, bleeding, fatigue, and constant infections. You order CBC and find low platelet count, low WBC’s, low RBC’s (anemia). B cells elevated. Upon PE, you feel enlarged liver, spleen. Child also has bone pain and anorexia. Dx and tx?
B-ALL. Tx- chemo, then BMT
What is TDT
equals DNTT (terminal transferase)- expressed in IMMATURE, pre-B, or pre-T lymphoid cells and acute lymphoblastic leukemia/lymphoma cells. This is important marker that tells you about level of maturation in leukemia
What can markers on the cells tell you?
Tell you about lineage (B cell vs. T cell) and level of maturation
What markers tell you if leukemia is precursor of lymphoid cell vs. more differentiated cell (mature B or T cell?)
TdT, CD34, and CD10
How does B-ALL occur?
Theory- due to translocations. Environment and genetics also may predispose a person- radiation, organic solvents, NF (neurofibromatosis), and down syndrome
What is neurofibromatosis
mutation in tumor suppressor gene
Prevalence of T-ALL in children and adults
T-ALL accounts for 15% of all childhood ALL, 25% of all ALL in adults is T-ALL
Translocation in T-ALL
Between T-cell receptor chains and transcription factor genes
Pathology of T-ALL
Presence of early T-cell antigens- CD7 followed by CD2 and CD5. During thymic differentiation the T-cells become positive for CD1a and CD3, CD4 and CD8. Lymphoblasts are positive for the TdT enzyme.
Prognosis of T-ALL
worse in children compared to B-ALL, but better in adults compared to B-ALL
Clinical features in T-ALL
anemia, thrombocytopenia, WBC count HIGH, mediastinal masses, lymphadenopathy, organomegaly, pleural effusions present
CLL and ALL more common in which age groups
CLL- elderly
All- 3-7 years
CLL diagnosis requires…
lymphocyte count HIGH >4,000/ul
Most common leukemia of adults
CLL
CLL diagnosis
anemia, thrombocytopenia, high lymphocyte count >4,000/ul, HIGH WBC COUNT, lymphadenopathy, splenomegaly
WBC count in SLL vs. CLL
CLL- leukocytosis
SLL- leucopenia
Pheonotype of CLL
CD19, CD20, CD23, and CD5
What does a low level of surface expression of Ig in CLL tell you?
little ability for B cells to differentiate into plasma cells and produce antibodies, resulting in weak immune response
Translocations or deletions in CLL?
DELETIONS more common, especially in chromosomes 11, 13, and 17
Deletion in chromosome 13…
worse prognosis, because chromosome 13 contains the tumor suppressor gene
What would cause worse prognosis in CLL?
deletions of 11q and 17p, expression of ZAP-70, unmutated Ig
What contributes to increased susceptivility to infections in CLL?
Hypogammaglobulinemia- causes low levels of antibodies in the blood
What can CLL transform to?
Prolymphocyte transformation in 15-30% of patients, and transformation to diffuse large B-cell lymphoma (Richter syndrome) in 5-10% of patients